The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like The Numbers Are In: Bay Area's Depomed Reveals 328 Job Cuts in WARN Notice December 28, 2017 With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017 Axovant's Much-Hyped Alzheimer's Drug Flunks Phase III Test September 25, 2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017
